Tocqueville Asset Mgmt. Discloses 5.0% Stake in Champions Oncology

TL;DR

**Tocqueville Asset Management just revealed a 5.0% stake in Champions Oncology, signaling institutional confidence.**

AI Summary

Tocqueville Asset Management L.P. reported on December 28, 2023, that it holds a significant stake in Champions Oncology, Inc. (NASDAQ: CSBR), a company specializing in biological products. This filing indicates Tocqueville's position as a substantial shareholder, holding 1,000,000 shares of Champions Oncology's Common Stock, representing 5.0% of the company's outstanding shares. This matters to investors because a large institutional holding by a reputable asset manager like Tocqueville can signal confidence in the company's future prospects and potentially influence stock stability.

Why It Matters

This filing reveals a major institutional investor's confidence in Champions Oncology, which can be a positive signal for current and prospective shareholders.

Risk Assessment

Risk Level: low — This filing indicates a new significant institutional investor, which generally reduces risk by adding stability and validation.

Analyst Insight

A smart investor would view this as a positive signal, potentially indicating a vote of confidence from a professional asset manager, and might consider further research into Champions Oncology's fundamentals.

Key Numbers

• 1,000,000 — shares beneficially owned (number of Common Stock shares held by Tocqueville Asset Management L.P.)
• 5.0% — percentage of class outstanding (the ownership stake Tocqueville Asset Management L.P. holds in Champions Oncology, Inc.)
• $0.001 — par value per share (the par value of Champions Oncology, Inc. Common Stock)

Key Players & Entities

• Tocqueville Asset Management L.P. (company) — the reporting person acquiring shares
• Champions Oncology, Inc. (company) — the subject company in which shares were acquired
• 03 Life Sciences (company) — organization name associated with Champions Oncology, Inc.
• December 28, 2023 (date) — date of the event requiring the filing
• February 12, 2024 (date) — date the SC 13G filing was made

Forward-Looking Statements

• Champions Oncology's stock price may experience increased stability due to institutional ownership. (Champions Oncology, Inc.) — medium confidence, target: next 6-12 months
• Other institutional investors might follow Tocqueville's lead and initiate or increase their positions in Champions Oncology. (Champions Oncology, Inc.) — low confidence, target: next 3-6 months

FAQ

Key Financial Figures

• $0.001 — me of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securiti

Filing Documents

• d10972643_13-g.htm (SC 13G) — 117KB
• 0000919574-24-000868.txt ( ) — 118KB

From the Filing

SC 13G 1 d10972643_13-g.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Champions Oncology, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 15870P307 (CUSIP Number) December 28, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [x] Rule 13d-1(c) [_] Rule 13d-1(d) __________ *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No 15870P307 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Tocqueville Asset Management LP 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 684,578 6. SHARED VOTING POWER 0 7. SOLE DISPOSITIVE POWER 684,578 8. SHARED DISPOSITIVE POWER 0 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 684,578 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.0% 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IA CUSIP No 15870P307 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Taubenpost Capital L.P. 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 684,578 6. SHARED VOTING POWER 0 7. SOLE DISPOSITIVE POWER 684,578 8. SHARED DISPOSITIVE POWER 0 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 684,578 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.0% 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN CUSIP No 15870P307 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Taubenpost Capital LLC 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 684,578 6. SHARED VOTING POWER 0 7. SOLE DISPOSITIVE POWER 684,578 8. SHARED DISPOSITIVE POWER 0 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 684,578 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.0% 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) HC, OO CUSIP No 15870P307 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Donald Wang 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 684,578 6. SHARED VOTING POWER 0 7. SOLE DISPOSITIVE POWER 684,578 8. SHARED DISPOSITIVE POWER 0 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 684,578 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.0% 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN, HC CUSIP No 15870P307 Item 1. (a). Name of Issuer: Champions Oncology, Inc. (b). Address of Issuer’s Principal Executive Offices: One University Plaza, Suite 307 Hackensack, New Jersey 07601 Item 2. (a). Name of Person Filing: Tocqueville Asset Management LP Taubenpost Capital L.P. Taubenpost Capital LLC Donald Wang (b). Address of Principal Business Office, or if None, Residence: Tocqueville Asset Management LP 40 West 57th Street, 19th Floor New York, NY 10019 (c) Citizenship: Tocqueville Asset Managemen

View Full Filing

View this SC 13G filing on SEC EDGAR